An adequate learning curve is important in order to minimize complications. The surgeon should also be confident about the instrumentation to reduce the duration of surgery and radiation exposure. The major complications primarily occur in the immediate postoperative period and can be related both to the implant and to the surgical procedure. The correct surgical indication selleck chemical Dasatinib remains mandatory. Patients should be informed about the potential complications and the possible need for instrumentation removal.
Morbid obesity is one of the major health problems of the 21st century. Formally recognized by the WHO as a global epidemic in 1997, it was estimated that in 2008, 1.5 billion adults, 20 and older, were overweight. Of these, over 200 million men and nearly 300 million women were obese, with higher rates among women than men.

The rate of obesity also increases with age at least up to 50 or 60 years old and severe obesity in the United States, Australia, and Canada is increasing faster than the overall rate of obesity. Once considered a problem only of high-income countries, obesity rates are rising worldwide and affecting both the developed and developing world. These increases have been felt most dramatically in urban settings [1]. Concurrently research on factors regulating obesity as well as possible treatments has been ongoing, with bariatric surgery making the greatest leaps and providing the means for better understanding of the metabolic and endocrine parameters involved in weight gain and weight loss [2, 3].

As the most effective means for excess weight loss available, bariatric surgery has been growing continuously, with more and more patients opting for surgical treatment of their condition, new operations and techniques being developed, and new instruments being produced. The advantages of minimally invasive surgery have been instrumental for this growth [4]. Many operations have been devised, with the Roux en Y gastric bypass being the most effective as far as excess weight loss is concerned, and sleeve gastrectomy being preferred by a growing number of surgeons due to its simplicity, effectiveness, and low rate of complications. In 2006, a new technique was presented, initially named total vertical gastric plication, better known today as laparoscopic greater curvature plication (Evidence Level III) [5].

Developed in Iran by Dr Talebpour as a cheap alternative to Laparoscopic Sleeve Gastrectomy, it appears to be gaining ground as its theoretical advantages of technical simplicity and low complication rate are of major importance Anacetrapib to the growing industry that Bariatric Surgery has become, as well as to the industry of Bariatric Tourism. 2. Aim Laparoscopic Greater Curvature Plication (LGCP) or Gastric Plication is a relatively new technique. Gastric Plication was initially proposed by Wilkinson and Peloso [6] in 1981 and introduced in 2006 by Dr Talebpour in Iran [5].